Zusammenfassung
Die Symptome bei HirntumorpatientInnen sind abhängig von der Lage des Tumors und der möglichen Beeinflussung eloquenter Hirnareale wie Lähmungen, Gefühlsstörungen, Ausfall von Sinneswahrnehmungen, Sprachstörungen, epileptische Anfälle, Änderung der Persönlichkeit, oder durch Erhöhung des Hirndruckes wie Kopfschmerzen besonders am Morgen, Übelkeit und Erbrechen, Somnolenz bis zum Bewusstseinsverlust.
Die Einstellung zu Bewegungstraining bei KrebspatientInnen hat sich in den letzten Jahrzehnten grundlegend geändert; weg vom Prinzip, dass Kranke sich primär schonen müssten, hin zur Erkenntnis, dass ein an individuellen Fähigkeiten angepasstes Bewegungstraining viele positive Effekte über den Erhalt von Kondition und Beweglichkeit hinaus, bieten kann. Dies zeigt einen größeren Einfluss auf die Überlebenszeit der HirntumorpatientInnen als jegliche bisher bekannte medikamentöse Therapie. Weiters zeigt es auf, wie wichtig es ist, die PatientInnen zur Beibehaltung von Bewegungstraining auch über die Dauer eines ambulanten oder stationären Rehabilitationsprogramms hinaus zu motivieren.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Archibald YM, Lunn D, Ruttan LA et al (1994) Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80(2):247–253
Armstrong TS, Wefel JS, Wang M et al (2013) Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol 31(32):4076–4084
Bartolo M, Zucchella C, Pace A et al (2012a) Improving neuro-oncological patients care: basic and practical concepts for nurse specialist in neuro-rehabilitation. J Exp Clin Cancer Res 31:82
Bartolo M, Zucchella C, Pace A et al (2012b) Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol 107(3):537–544
Boele FW, Douw L, de Groot M et al (2013) The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro Oncol 15(10):1420–1428
Boele FW, Zant M, Heine EC et al (2014) The association between cognitive functioning and health-related quality of life in low-grade glioma patients. Neurooncol Pract 1(2):40–46
Butler JM Jr, Case LD, Atkins J et al (2007) A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69(5):1496–1501
Capozzi LC, Boldt KR, Easaw J, Bultz B, Culos-Reed SN (2016) Evaluating a 12-week exercise program for brain cancer patients. Psychooncology 25(3):354–358
Day J, Gillespie DC, Rooney AG et al (2016) Neurocognitive deficits and neurocognitive rehabilitation in adult brain tumors. Curr Treat Options Neurol 18(5):22
De Wit L, Putman K, Dejaeger E et al (2005) Use of time by stroke patients: a comparison of four European rehabilitation centers. Stroke 36(9):1977–1983
De Wit L, Putman K, Schuback B et al (2007) Motor and functional recovery after stroke: a comparison of 4 European rehabilitation centers. Stroke 38(7):2101–2107
Eakin EG, Hayes SC, Haas MR et al (2015) Healthy living after cancer: a dissemination and implementation study evaluating a telephone-delivered healthy lifestyle program for cancer survivors. BMC Cancer 15:992
Flechl B, Ackerl M, Sax C et al (2012) Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J Neurooncol 109(2):331–339
Flechl B, Ackerl M, Sax C et al (2013) The caregivers’ perspective on the end-of-life phase of glioblastoma patients. J Neurooncol 112(3):403–411
Gehring K, Sitskoorn MM, Gundy CM et al (2009) Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 27(22):3712–3722
Gehring K, Patwardhan SY, Collins R et al (2012) A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol 107(1):165–174
Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370(8):699–608
Goodwin TL, Sainani K, Fisher PG (2009) Incidence patterns of central nervous system germ cell tumors: a SEER Study. J Pediatr Hematol Oncol 31(8):541–544
Hansen A, Rosenbek Minet LK, Sogaard K, Jarden JO (2014) The effect of an interdisciplinary rehabilitation intervention comparing HRQoL, symptom burden and physical function among patients with primary glioma: an RCT study protocol. BMJ Open 4(10):e005490
Hassler MR, Elandt K, Preusser M et al (2010) Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol 97(1):109–115
Johansson BB (2000) Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke 31(1):223–230
Jones LW, Cohen RR, Mabe SK et al (2009) Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. J Neurooncol 94(1):79–85
Jones LW, Friedman AH, West MJ et al (2010a) Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma. Cancer 116(3):695–704
Jones LW, Mourtzakis M, Peters KB et al (2010b) Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study. Oncologist 15(6):636–647
Keilani M, Krall C, Marosi C et al (2012) Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients. Wien Klin Wochenschr 124(11–12):377–383
Khan F, Amatya B (2013) Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour. J Neurooncol 111(3):355–366
Khan F, Amatya B, Drummond K, Galea M (2014) Effectiveness of integrated multidisciplinary rehabilitation in primary brain cancer survivors in an Australian community cohort: a controlled clinical trial. J Rehabil Med 46(8):754–760
Khan F, Amatya B, Ng L, Drummond K, Galea M (2015) Multidisciplinary rehabilitation after primary brain tumour treatment. Cochrane Database Syst Rev 8:CD009509
Khan F, Amatya B, Galea MP, Gonzenbach R, Kesselring F (2016) Neurorehabilitation: applied neuroplasticity. J Neurol 264(3):603–615
Kirshblum S, O’Dell MW, Ho C, Barr K (2001) Rehabilitation of persons with central nervous system tumors. Cancer 92(4 Suppl):1029–1038
Klein M, Heimans JJ (2004) The measurement of cognitive functioning in low-grade glioma patients after radiotherapy. J Clin Oncol 22(5):966–967; author reply 967–968
Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343):1361–1368
Klein M, Heimans JJ, Aaronson NK et al (2004) Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants. Ned Tijdschr Geneeskd 148(44):2175–2180
Koekkoek JA, Kerkhof M, Dirven L et al (2014) Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study. BMC Neurol 14:157
Kolb B, Teskey GC (2012) Age, experience, injury, and the changing brain. Dev Psychobiol 54(3):311–325
Laack NN, Brown PD, Ivnik RJ et al (2005) Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 63(4):1175–1183
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803–820
Marson DC, Martin RC, Triebel KL, Nabors LB (2010) Capacity to consent to research participation in adults with malignant glioma. J Clin Oncol 28(24):3844–3850
Meyers CA, Weitzner MA, Valentine AD, Levin VA (1998) Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16(7):2522–2527
Noll KR, Weinberg JS, Ziu M, Benveniste RJ, Suki D, Wefel JS (2015) Neurocognitive changes associated with surgical resection of left and right temporal lobe glioma. Neurosurgery 77(5):777–785
Pang TY, Hannan AJ (2013) Enhancement of cognitive function in models of brain disease through environmental enrichment and physical activity. Neuropharmacology 64:515–528
Pokhrel KP, Vovoras D, Tsokos CP (2012) Histological and demographic characteristics of the distribution of brain and central nervous system tumors’ sizes: results from SEER registries using statistical methods. Int J Biomed Sci 8(3):152–162
Prokopenko M (2009) Guided self-organization. HFSP J 3(5):287–289
Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M (2016) Advances in the molecular genetics of gliomas – implications for classification and therapy. Nat Rev Clin Oncol 14(7):434–452
Ruden E, Reardon DA, Coan AD et al (2011) Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. J Clin Oncol 29(21):2918–2923
Schmitz KH, Courneya KS, Matthews C et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426
Schunemann MS, Anker D, Rauchhaus M (2008) Cancer fatigue syndrome reflects clinically non-overt heart failure: an approach towards onco-cardiology. Nat Clin Pract Oncol 5(11):632–633
Shaw EG, Rosdhal R, D’Agostino RB Jr et al (2006) Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 24(9):1415–1420
Taphoorn MJ, Schiphorst AK, Snoek FJ et al (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36(1):48–54
Wade D (2015a) Rehabilitation-a new approach. Overview and part one: the problems. Clin Rehabil 29(11):1041–1050
Wade D (2015b) Rehabilitation – a new approach. Part two: the underlying theories. Clin Rehabil 29(12):1145–1154
Wefel JS, Noll KR, Rao G, Cahill DP (2016) Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection. Neuro Oncol 18(12):1656–1663
Wöhrer A, Waldhör T, Heinzl H et al (2009) The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95(3):401–411
Wolin KY, Schwartz AL, Matthews CE, Courneya KS, Schmitz KH (2012) Implementing the exercise guidelines for cancer survivors. J Support Oncol 10(5):171–177
Yang S, Chun MH, Son YR (2014) Effect of virtual reality on cognitive dysfunction in patients with brain tumor. Ann Rehabil Med 38(6):726–733
Zucchella C, Capone A, Codella V et al (2013) Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neurooncol 114(1):93–100
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Marosi, C. (2020). Ausgangslage für Rehabilitationsmaßnahmen bei HirntumorpatientInnen. In: Crevenna, R. (eds) Onkologische Rehabilitation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57982-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-57982-4_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57981-7
Online ISBN: 978-3-662-57982-4
eBook Packages: Medicine (German Language)